# myTomorrows

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mytomorrows

- Industry: Healthcare IT
- Headquarters: Amsterdam, Netherlands
- Website: www.mytomorrows.com
- Total disclosed funding: $35M
- Latest round: Series C (Oct 1, 2025)
- Investors on record: 3

## About

Founded in 2012 and based in Amsterdam, Netherlands, Impatients N.V. doing business as myTomorrows provides a technology-driven platform that bridges the gap between patients, physicians, and BioPharma companies to enable access to treatments still in development. Its services include facilitating participation in clinical trials, managing Expanded Access Programs (EAPs), and supporting real-world data collection for pharmaceutical partners. 
In October 2025, myTomorrows raised USD 29 million in series C funding from new investor Avego.

## Funding rounds

- Series C, Oct 1, 2025, $29M — Avego
- Series A, Nov 7, 2014, $5.6M — Sofinnova Partners, Balderton Capital

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- Balderton Capital (https://capitalatlas.ai/funds/balderton-capital) — Series A
- Avego (https://capitalatlas.ai/funds/avego) — Series C